These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 24398905)
1. Measurement of urinary canine S100A8/A9 and S100A12 concentrations as candidate biomarkers of lower urinary tract neoplasia in dogs. Heilmann RM; Wright ZM; Lanerie DJ; Suchodolski JS; Steiner JM J Vet Diagn Invest; 2014 Jan; 26(1):104-12. PubMed ID: 24398905 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma. Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528 [TBL] [Abstract][Full Text] [Related]
3. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma. Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489 [TBL] [Abstract][Full Text] [Related]
4. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs. Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Alber G; Kiefer I; Steiner JM; Seeger J; Heilmann RM BMC Vet Res; 2023 Nov; 19(1):234. PubMed ID: 37946179 [TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome. Thames BE; Barr JW; Suchodolski JS; Steiner JM; Heilmann RM J Vet Diagn Invest; 2019 Jul; 31(4):645-651. PubMed ID: 31170888 [TBL] [Abstract][Full Text] [Related]
6. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy. Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs. Sotirakopoulos AJ; Armstrong PJ; Heath L; Madrill NJ; McNiel EA J Vet Intern Med; 2010; 24(6):1445-51. PubMed ID: 21039871 [TBL] [Abstract][Full Text] [Related]
8. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Lorenz E; Muhlebach MS; Tessier PA; Alexis NE; Duncan Hite R; Seeds MC; Peden DB; Meredith W Respir Med; 2008 Apr; 102(4):567-73. PubMed ID: 18164192 [TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of the BRAF variant V595E in urine samples, smears and biopsies from canine transitional cell carcinoma]. Aupperle-Lellbach H; Grassinger J; Hohloch C; Kehl A; Pantke P Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):289-295. PubMed ID: 30541168 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples. Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Henry CJ; Tyler JW; McEntee MC; Stokol T; Rogers KS; Chun R; Garrett LD; McCaw DL; Higginbotham ML; Flessland KA; Stokes PK Am J Vet Res; 2003 Aug; 64(8):1017-20. PubMed ID: 12926595 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a bladder tumor antigen test for the diagnosis of lower urinary tract malignancies in dogs. Billet JP; Moore AH; Holt PE Am J Vet Res; 2002 Mar; 63(3):370-3. PubMed ID: 11926180 [TBL] [Abstract][Full Text] [Related]
13. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study. Ludwig S; Stephan C; Lein M; Loening SA; Jung K Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245 [TBL] [Abstract][Full Text] [Related]
14. A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine. Bracha S; McNamara M; Hilgart I; Milovancev M; Medlock J; Goodall C; Wickramasekara S; Maier CS Anal Biochem; 2014 Jun; 455():41-7. PubMed ID: 24704347 [TBL] [Abstract][Full Text] [Related]
15. Changes in S100A8/A9 and S100A12 and Their Comparison with Other Analytes in the Saliva of Pigs with Diarrhea Due to Ortín-Bustillo A; Botía M; López-Martínez MJ; Martínez-Subiela S; Cerón JJ; González-Bulnes A; Manzanilla EG; Goyena E; Tecles F; Muñoz-Prieto A Animals (Basel); 2023 Aug; 13(16):. PubMed ID: 37627347 [TBL] [Abstract][Full Text] [Related]
16. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer. Allen DK; Waters DJ; Knapp DW; Kuczek T J Vet Intern Med; 1996; 10(4):231-4. PubMed ID: 8819047 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma. Hamlin AN; Chadwick LE; Fox-Alvarez SA; Hostnik ET Vet Radiol Ultrasound; 2019 Sep; 60(5):552-559. PubMed ID: 31144408 [TBL] [Abstract][Full Text] [Related]